Clinical review: Corticotherapy in sepsis
Authors:
Open Access
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 8 (2) , 122-9
Abstract
The use of glucocorticoids (corticotherapy) in severe sepsis is one of the main controversial issues in critical care medicine. These agents were commonly used to treat sepsis until the end of the 1980s, when several randomized trials casted serious doubt on any benefit from high-dose glucocorticoids. Later, important progress in our understanding of the role played by the hypothalamic–pituitary–adrenal axis in the response to sepsis, and of the mechanisms of action of glucocorticoids led us to reconsider their use in septic shock. The present review summarizes the basics of the physiological response of the hypothalamic–pituitary–adrenal axis to stress, including regulation of glucocorticoid synthesis, the cellular mechanisms of action of glucocorticoids, and how they influence metabolism, cardiovascular homeostasis and the immune system. The concepts of adrenal insufficiency and peripheral glucocorticoid resistance are developed, and the main experimental and clinical data that support the use of low-dose glucocorticoids in septic shock are discussed. Finally, we propose a decision tree for diagnosis of adrenal insufficiency and institution of cortisol replacement therapy.Keywords
This publication has 49 references indexed in Scilit:
- Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axisInnate Immunity, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Relative eosinophilla and functional adrenal insufficiency in critically ill patientsThe Lancet, 1999
- A comparison of the adrenocortical response during septic shock and after complete recoveryIntensive Care Medicine, 1996
- Are endogenous glucocorticoid levels adequate in septic shock?Intensive Care Medicine, 1996
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Hypocortisolaemia and adrenocortical responsiveness at onset of septic shockIntensive Care Medicine, 1994
- Adrenocortical function: An indicator of severity of disease and survival in chronic critically ill patientsIntensive Care Medicine, 1992
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987